Iron Status of Non-anemic Pregnant Women in First Trimester
Establishment of Reference Intervals for Iron Test Panel for Pregnant Women at Hung Vuong Hospital
1 other identifier
observational
600
1 country
1
Brief Summary
This cross-sectional study aims to establish reference intervals for iron biomarkers-including serum iron, ferritin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT)-in healthy pregnant women during the first trimester. Additionally, the study will investigate the current prevalence of non-anemic iron deficiency (NAID) in this population. By applying strict inclusion and exclusion criteria to eliminate potential confounding factors, the study seeks to provide a reliable baseline for evaluating iron status and early detection of iron deficiency without anemia among pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2025
CompletedFirst Submitted
Initial submission to the registry
May 18, 2025
CompletedFirst Posted
Study publicly available on registry
May 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedMay 30, 2025
May 1, 2025
4 months
May 18, 2025
May 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Prevalence of iron supplement using women that has non-anemic iron deficiency in the first trimester
Non-anemic iron deficiency is defined as hemoglobin ≥ 11 g/dL and transferrin saturation (TSAT) \< 20%. The prevalence will be calculated as the proportion of enrolled pregnant women meeting these criteria
At baseline (upon enrollment)
Prevalence of non iron supplement using women that has non-anemic iron deficiency in the first trimester
Non-anemic iron deficiency is defined as hemoglobin ≥ 11 g/dL and transferrin saturation (TSAT) \< 20%. The prevalence will be calculated as the proportion of enrolled pregnant women meeting these criteria
At baseline (upon enrollment)
Reference Intervals for Iron Biomarkers in the First Trimester
Establish reference intervals (2.5th-97.5th percentile) for serum iron, ferritin, TIBC, and TSAT in healthy first-trimester pregnant women meeting inclusion criteria
At baseline (upon enrollment)
Study Arms (2)
With iron supplement
Pregnant women who are taking iron supplement
Without iron supplement
Pregnant women who are not taking any iron supplement
Eligibility Criteria
Pregnant women
You may qualify if:
- Pregnant women attending antenatal care, carrying a single live fetus.
- Systolic blood pressure at the time of examination \< 140 mmHg.
- Diastolic blood pressure at the time of examination \< 90 mmHg.
- Body temperature at the time of examination between \>35°C and \<37.5°C.
- Hemoglobin ≥ 11 g/dL
You may not qualify if:
- History of diabetes mellitus, hypertension, hemoglobinopathies, leukemia, non-hematologic cancers, systemic lupus erythematosus, Gastrointestinal diseases (Celiac disease, Crohn's disease and ulcerative colitis, Gastric diseases or prior gastrointestinal surgery, Irritable bowel syndrome, etc).
- Currently on gastric acid-suppressing medications: Proton pump inhibitors (e.g., Omeprazole, Lansoprazole, Esomeprazole...), H2 receptor antagonists (e.g., Ranitidine, Famotidine, Cimetidine...), Positive screening for Treponema pallidum, HBsAg, or HIV.
- Use of stimulants or tobacco smoking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hung Vuong Hospital
Ho Chi Minh City, Ho Chi Minh, 70000, Vietnam
Related Publications (5)
Auerbach M, Abernathy J, Juul S, Short V, Derman R. Prevalence of iron deficiency in first trimester, nonanemic pregnant women. J Matern Fetal Neonatal Med. 2021 Mar;34(6):1002-1005. doi: 10.1080/14767058.2019.1619690. Epub 2019 Jun 3.
PMID: 31154873BACKGROUNDFisher AL, Nemeth E. Iron homeostasis during pregnancy. Am J Clin Nutr. 2017 Dec;106(Suppl 6):1567S-1574S. doi: 10.3945/ajcn.117.155812. Epub 2017 Oct 25.
PMID: 29070542BACKGROUNDDaru J, Allotey J, Pena-Rosas JP, Khan KS. Serum ferritin thresholds for the diagnosis of iron deficiency in pregnancy: a systematic review. Transfus Med. 2017 Jun;27(3):167-174. doi: 10.1111/tme.12408. Epub 2017 Apr 20.
PMID: 28425182BACKGROUNDMei Z, Addo OY, Jefferds MED, Flores-Ayala RC, Brittenham GM. Physiologically based trimester-specific serum ferritin thresholds for iron deficiency in US pregnant women. Blood Adv. 2024 Jul 23;8(14):3745-3753. doi: 10.1182/bloodadvances.2024013460.
PMID: 38781318BACKGROUNDPasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021 Jan 16;397(10270):233-248. doi: 10.1016/S0140-6736(20)32594-0. Epub 2020 Dec 4.
PMID: 33285139BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
May 18, 2025
First Posted
May 25, 2025
Study Start
March 12, 2025
Primary Completion
June 30, 2025
Study Completion
August 30, 2025
Last Updated
May 30, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- Individual participant data will be made available beginning 6 months after publication of the main study results and will remain accessible. Data requests during this time will be reviewed and approved by the principal investigator and ethics board, subject to a data use agreement.
- Access Criteria
- De-identified individual participant data (IPD) will be made publicly available via a trusted data repository (e.g., Figshare) beginning 6 months after publication. No specific request or proposal is required for access. Users will be able to freely download the dataset under a standard data use license (e.g., Creative Commons Attribution \[CC BY 4.0\]). All shared data will be stripped of personal identifiers to protect participant confidentiality. A link to the dataset will be provided in the publication and on institutional or project websites.
Yes, the investigators plan to share individual participant data (IPD) that underlie the results reported in future publications, including de-identified data on hemoglobin, serum iron, ferritin, TIBC, transferrin saturation (TSAT), maternal demographics (age, BMI, gestational age), and relevant inclusion/exclusion criteria. Data will be available upon reasonable request for research purposes, following approval by the principal investigator and ethics board, and under a data-sharing agreement to ensure confidentiality and appropriate use.